Phathom Pharmaceuticals, Inc. (PHAT) › Operating IncomePhathom Pharmaceuticals, Inc. (PHAT) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2018: -$1.23M2019: -$106.22M2020: -$125.67M2021: -$135.08M2022: -$172.44M2023: -$167.31M2024: -$277.47M2025: -$159.99M-$159.99M2018Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$159.99M+42.3%2024-$277.47M-65.8%2023-$167.31M+3.0%2022-$172.44M-27.7%2021-$135.08M-7.5%2020-$125.67M-18.3%2019-$106.22M-8570.6%2018-$1.23M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share